Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Lack of Physician Documentation for Not Following Pharmacy Medication Monitoring Recommendation

Jackson, Michigan Survey Completed on 04-16-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that the attending physician documented the rationale for not implementing a pharmacy recommendation regarding medication monitoring for a resident. The resident, who had vascular dementia and catatonic schizophrenia, was prescribed carbamazepine as a mood stabilizer. The consultant pharmacist recommended obtaining a baseline carbamazepine level and periodic monitoring to optimize efficacy and reduce toxicity, as well as other laboratory tests. While the physician responded to the pharmacist's recommendation by ordering CBC, CMP, and ophthalmology follow-up, there was no documentation or explanation in the medical record as to why the carbamazepine level was not obtained as recommended. Record review and interviews confirmed that the rationale for not following the pharmacy's recommendation was not documented by the attending physician at the time. The DON reported that the nurse practitioner stated carbamazepine levels were not necessary since the medication was being used for catatonic schizophrenia rather than seizures, but this explanation was not entered into the medical record until an addendum was made after the issue was identified. The lack of timely documentation of the physician's rationale constituted the deficiency.

An unhandled error has occurred. Reload 🗙